Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
02/2010
02/17/2010EP1240186B1 Improvements in or relating to immune responses to hiv
02/17/2010CN201404486Y Controlled-release micro sphere of chitosan coating 3,5-dyhydroxy-4-isopropyl toluylene
02/17/2010CN100589809C Quaternised ammonium cyclodextrin compounds
02/16/2010US7662938 2′-fluoronucleosides
02/16/2010US7662933 Pegylated granulocyte colony stimulating factor (G-CSF) to treat a hematopoietic disorder related to reduced neutrophil count, such as infectious disease, sepsis, or a result of radiotherapy or chemotherapy
02/16/2010US7662921 Methods of treating viral disorders
02/16/2010US7662916 Modified HIV Env polypeptides
02/16/2010US7662860 Cinanserin analogs were synthesized and tested at molecular and viral levels and were found to be able to inhibit the SARS-CoV virus 3CL Protease and SARS-CoV viruses, and may be used for treating and/or preventing SARS-CoV virus infection
02/16/2010US7662856 Compositions having antimycrobial activity including a hydroxamate or a hydroxamate and a hydroxlyamine
02/16/2010US7662852 Compounds and preparations having antiviral effect
02/16/2010US7662825 2,3-Dichloro-N-(3-methoxy-5-methyl-2-pyrazinyl)-benzenesulphonamide; inflammatory diseases, such as asthma
02/16/2010US7662822 Substituted azaquinazolines having an antiviral action
02/16/2010US7662817 Psychological disorders; central nervous system disorders; antidepressants; anxiolytic agents; stress reliever; irritable bowel syndrome
02/16/2010US7662810 2-arylmethylazetidine carbapenem derivatives and preparation thereof
02/16/2010US7662807 Sulphonated meso-tetraphenyl chlorins
02/16/2010US7662798 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
02/16/2010US7662633 Method of screening for inhibitors of osteopontin
02/16/2010US7662575 identifying Francisella tularensis vaccine candidates. It enables identification of novel vaccine candidates and quality assurance for vaccine batches, assessment of protection in vaccinates and identification of the infecting agent in vaccinates. Mice were first vaccinated with Brucella infections
02/16/2010US7662548 Method of screening for modulators of HIV infection
02/16/2010US7662395 Recombinant virus encoding an antigen of a disease state; second recombinant virus encoding an immunostimulatory molecule with an exogenous immunostimulatory molecule, chemotherapeutic drug, antibiotic, antiviral drug or antifungal drug.
02/16/2010US7662394 Nucleic acids encoding chimeric Flavivirus immunogens comprising the Japanese encephalitis virus (JEV) PRM signal sequence
02/16/2010US7662391 Polynucleotide sequence for Chalmydia pneumonia; therapy, prevention of Chlamydia infections ; vaccines
02/16/2010CA2628224C Vinyl-pyrrolidinone cephalosporins with basic substituents
02/16/2010CA2455224C Use of pyrimidine nucleosides and/or the prodrugs thereof for combating the side-effects of haart (highly active anti-retroviral therapy) and other anti-viral therapies
02/16/2010CA2429109C Anti-inflammatory agents
02/16/2010CA2421721C Therapeutic topical solution for skin and associated methods of use
02/16/2010CA2406095C Synthetic process for the manufacture of an ecteinaschidin compound
02/16/2010CA2402436C Amidino compound and salts thereof useful as nitric oxide synthase inhibitors
02/16/2010CA2385938C Cyclic amine compounds as ccr5 antagonists
02/16/2010CA2225822C Nitroimidazole antibacterial compounds and methods of use thereof
02/16/2010CA2224444C Type f botulinum toxin and use thereof
02/11/2010WO2010017514A2 Methods of predicting cancer lethality using replikin counts
02/11/2010WO2010017401A1 Bi-1h-benzimidazoles as hepatitis c virus inhibitors
02/11/2010WO2010017355A2 Small molecule inhibitors of retroviral assembly and maturation
02/11/2010WO2010017317A2 Use of mtor inhibitors to enhance t cell immune responses
02/11/2010WO2010017131A2 Modulation of toll-like receptor 7 expression by antisense oligonucleotides
02/11/2010WO2010017060A1 Urea derivatives as antibacterial agents
02/11/2010WO2010015148A1 Oligodeoxynucleotides with function of immunosuppression
02/11/2010WO2009093141A3 Novel inhibitors of mycobacterium complex cytochrome p450 cyp121
02/11/2010WO2008010070A3 Novel oxazolidinone derivatives
02/11/2010US20100036084 Biodegradable poly(beta-amino esters) and uses thereof
02/11/2010US20100035987 Pleuromutilin derivatives for the treatment of diseases mediated by microbes
02/11/2010US20100035976 Method of treating a tumor or a viral disease by administering a 2' , 5' -oligoadenylate analog
02/11/2010US20100035975 Methods of preventing and treating respiratory viral infection using immunomodulatory polynucleotide sequences
02/11/2010US20100035956 Compounds Having CRTH2 Antagonist Activity
02/11/2010US20100035948 Furanone compounds and lactam analogues thereof
02/11/2010US20100035945 Small molecule inhibitors of bacterial dam dna methyltransferases
02/11/2010US20100035943 Oxa-and thiadiazoles and their use as metalloproteinase inhibitors
02/11/2010US20100035939 Penetrating carrier, anti-fungal composition using the same and method for treatment of dermatophytes
02/11/2010US20100035925 Compounds, pharmaceutical compositions an dmethods for inhibiting hiv infectivity
02/11/2010US20100035912 Small Molecule Inhibitors of Retroviral Assembly and Maturation
02/11/2010US20100035894 Aqueous liquid preparation having improved intraocular gatifloxacin penetration
02/11/2010US20100035870 Pyrimidin-4-yl-3, 4-Dihydro-2H-Pyrrolo[1,2A] Pyrazin-1-one Compounds
02/11/2010US20100035856 Beta-LACTAM-CONTAINING FORMULATIONS WITH INCREASED STABILITY IN AQUEOUS SOLUTION
02/11/2010US20100035847 Genes for biosynthesis of tetracycline compounds and uses thereof
02/11/2010US20100035842 Amino alcohol compounds or phosphonic acid derivatives thereof
02/11/2010US20100035835 Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection
02/11/2010US20100035832 Macrolides
02/11/2010US20100035816 Medicament comprising a peptide extract of avocado, which is intended for the treatment and prevention of illnesses that are linked to an immune system deficiency or oxidative stress or skin ageing or dry skin
02/11/2010US20100034909 Pharmaceutical composition for treating rotavirus and/or respiratory syncytial virus infection and method for preparing the same
02/11/2010US20100034908 Porphyromonas gingivalis polypeptides and nucleotides
02/11/2010US20100034877 Use of lactobacillus for treatment of virus infections
02/11/2010US20100034875 Immunogenic compositions and methods of use
02/11/2010US20100034873 Transdermal ricinoleic acid compositions
02/11/2010US20100034862 Covalently grafted pharmaceutically active polymers
02/11/2010US20100034850 Vaccine
02/11/2010US20100034847 Multiple vaccination including Serogroup C Meningococcus
02/11/2010US20100034839 Methods for treating viral disorders
02/11/2010US20100034827 Novel hiv reverse transcriptase inhibitors
02/11/2010US20100034823 Crystalline anti-hTNFalpha antibodies
02/11/2010US20100034822 Haemophilus Influenzae Type B
02/11/2010US20100034810 Pyrimidine derivatives for the prevention of hiv infection
02/11/2010US20100034807 Methods and compositions for discovery of target-specific antibodies using antibody repertoire array (ara)
02/11/2010US20100034776 Replication-competent anti-cancer vectors
02/11/2010US20100034774 Serotype of adenovirus and uses thereof
02/11/2010US20100034773 5,6-dihydro-1h-pyridin-2-one compounds
02/11/2010US20100034747 Detection of HIV-1 Infection
02/11/2010US20100034744 Method For Screening Anti-HIV Drugs and A Diagnostic Method of AIDS
02/11/2010DE102008041049A1 Use of a composition comprising one or more of methacrylic acid and methacrylic acid ester as a medicament for topical treatment of fungal disease of the foot and/or fingernails
02/11/2010CA2735710A1 Sting (stimulator of interferon genes), a regulator of innate immune responses
02/11/2010CA2733461A1 Methods of predicting cancer lethality using replikin counts
02/11/2010CA2733203A1 Use of mtor inhibitors to enhance t cell immune responses
02/11/2010CA2732045A1 Urea derivatives as antibacterial agents
02/11/2010CA2730064A1 Small molecule inhibitors of retroviral assembly and maturation
02/10/2010EP2151451A1 Composition for preventing or treating lung disease
02/10/2010EP2151447A1 Lincomycin derivatives and antibacterial agents containing the same as the active ingredient
02/10/2010EP2151242A1 Use of oxygen for treatment of illnesses of the mucous membrane of the intestinal channel
02/10/2010EP2066678B1 Spiro antibiotic derivatives
02/10/2010EP1747196B1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
02/10/2010EP1490365B1 Azaindoles as inhibitors of c-jun n-terminal kinases
02/10/2010EP1404659B1 4-aryl quinols and analogs thereof as therapeutic agents
02/10/2010EP1278546B1 Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents
02/10/2010CN101643789A RNA interference mediating small RNA molecules
02/10/2010CN101643512A Novel immunoadhesin for the prevention of rhinovirus infection
02/10/2010CN100588660C Antigenic determinant of SARS coronavirus nucleocapsid protein and application thereof
02/10/2010CN100588650C Non-nucleoside reverse transcriptase inhibitors I for treating HIV mediated diseases
02/10/2010CN100588647C Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid
02/10/2010CN100588644C Eugenol ibuprofen ester medical compound and its preparation and preparation method
02/10/2010CN100588430C SARS-Cov gene vaccine based on epi-position and its contruction
02/10/2010CN100588404C Chinese traditional medicine compound injection and preparation method thereof
1 ... 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 ... 1798